Christine Sekaggya-Wiltshire, winner of the 2018 Stephen Lawn TB-HIV Research Leadership Prize, is profiled in The Lancet

Photograph of Christine Sekaggya-WiltshireThe Lancet has written a profile on Dr Christine Sekaggya-Wiltshire, as part of the prize for winning the Stephen Lawn TB-HIV Research Leadership Prize in 2018.

Dr Sekaggya-Wiltshire leads the tuberculosis and HIV clinic at the Infectious Diseases Institute (IDI) at Makerere University in Kampala, Uganda. The Lancet profile describes how Dr Sekaggya-Wiltshire started her career with a qualification in medicine in 2006 at Makerere University College of Health Sciences, and began work at Mulago National Referral Hospital in Kampala. She then developed an enthusiasm for evidence-based medicine and research, which she combines with her commitment to patient care.

Dr Sekaggya-Wiltshire currently supervises care for complex cases of TB that are referred from health centres, and has conducted various research studies, including studying the relationship between levels of anti-tuberculosis drugs in blood and patient outcome, and looking at the safety and efficacy of high dose rifampicin in HIV-infected patients.

Speaking in the article, Andrew Kambugu, Executive Director of the IDI at Makerere, says of Dr Sekaggya-Wiltshire, “She has a passion for teaching and mentoring the next generation”, he adds “Her motivation is to excite others about the value of research.” 

The Stephen Lawn Memorial Fund for TB and AIDS Research Leadership was set up to commemorate Stephen Lawn’s life, and work, and supports the Research Leadership Prize. The Prize recognises an upcoming researcher conducting promising work focused on reducing the disease burden of TB and HIV/AIDS in Africa. Last year’s award was presented to Dr Sekaggya-Wiltshire at the Union World Conference in The Hague.

Nominations for this year’s Research Leadership Prize are still open but are due to close shortly on 31 March 2019. This year’s prize will be presented in Hyderabad at the 50th Union World Conference on Lung Health and the winner of the prize will receive:

  • A full fellowship to attend the conference (including full delegate badge, travel, accommodation and per diem).
  • An award of GBP 1,000, and a certificate.
  • A profile/news item by The Lancet.
  • An invitation to attend the Stephen Lawn Memorial Lecture in March of the next year in London with an opportunity for the winner to present their work in a seminar, and network with colleagues.

This year’s Stephen Lawn Memorial Lecture will be held in Cape Town on 2 April 2019. The lecture is hosted by the Desmond Tutu HIV Foundation, UCT Faculty of Health Sciences, UCT Institute of Infectious Disease and Molecular Medicine, and the London School of Hygiene & Tropical Medicine (LSHTM).

Find out more about The Stephen Lawn TB-HIV Research Leadership Prize or make a nomination now. The Union will be reporting on the Stephen Lawn Memorial Lecture when it happens in April.